Lars Lindholm

Active 1984–2025

74
Papers
28,899
Citations
60
h-index
71
i10-index

Citations

Citations per year for Lars Lindholm1988: 1 citations1989: 1 citations1990: 1 citations1992: 6 citations1993: 12 citations1994: 13 citations1995: 11 citations1996: 14 citations1997: 26 citations1998: 37 citations1999: 34 citations2000: 61 citations2001: 90 citations2002: 133 citations2003: 244 citations2004: 326 citations2005: 299 citations2006: 319 citations2007: 291 citations2008: 231 citations2009: 175 citations2010: 224 citations2011: 207 citations2012: 201 citations2013: 196 citations2014: 159 citations2015: 139 citations2016: 116 citations2017: 108 citations2018: 103 citations2019: 246 citations2020: 234 citations2021: 250 citations2022: 250 citations2023: 218 citations2024: 314 citations2025: 171 citations2026: 11 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,542 citing papers, 21.5% of this breakdownUnited Kingdom: 629 citing papers, 8.7% of this breakdownItaly: 457 citing papers, 6.3% of this breakdownGermany: 331 citing papers, 4.6% of this breakdownAustralia: 293 citing papers, 4.1% of this breakdownChina: 293 citing papers, 4.1% of this breakdownCanada: 278 citing papers, 3.9% of this breakdownSweden: 273 citing papers, 3.8% of this breakdownJapan: 224 citing papers, 3.1% of this breakdownFrance: 214 citing papers, 3% of this breakdownNetherlands: 213 citing papers, 3% of this breakdownSpain: 180 citing papers, 2.5% of this breakdown
0%21.5%Other 31.4%

Fields

  • Medicine87.1%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Health Professions2.2%
  • Economics, Econometrics and Finance1.3%
  • Nursing1.1%
  • Psychology0.6%
  • Other4.1%

Topics

  • Blood Pressure and Hypertension Studies14.6%
  • Sodium Intake and Health3.8%
  • Hormonal Regulation and Hypertension3.7%
  • Renin-Angiotensin System Studies3.5%
  • Cardiovascular Health and Disease Prevention3.2%
  • Heart Failure Treatment and Management2.7%
  • Other68.5%

Coauthors

All papers

Open in search
  1. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Koon Teo, Carl J. Pepine, Barry R. Davis - The Lancet 2021 cited by 1,001

  2. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rury R. Holman, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, Kizuku Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, Masunori Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, Christopher R. Palmer, Anushka Patel, Marc Allan Pfeffer, Bertram Pitt, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, Takao Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Mark Woodward, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Zhen‐Yu Zhang, Craig S. Anderson, Colin Baigent, Barry M. Brenner, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi, Johan Sundström, Fiona Turnbull, Giancarlo Viberti, Ji‐Guang Wang, John Chalmers, Barry R. Davis and 2 more - The Lancet 2021 cited by 321

  3. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

    Authors: , , , , , , , , , , , , , , - The Lancet 2002 cited by 5,417

  4. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J A Cutler, Richard B Devereaux, Jamie P. Dwyer, R Estacio, Robert Fagard, Keith A.A. Fox, Tomohiro FUKUI, Yutaka Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Julia B. Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, Giuseppe Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Marc Allan Pfeffer, Neil R Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, Lindon Wing, Yoshiki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Rory Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi‐Khorshidi, Johan Sundström and 3 more - The Lancet Diabetes & Endocrinology 2022 cited by 102

  5. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Widimsky, José Luis Zamorano, SE Kjeldsen, Serap Erdine, Krzysztof Narkiewicz, W. Kiowski, Enrico Agabiti‐Rosei, E Ambrosioni, Renata Cífková, Anna F. Dominiczak, R. Fagard, A. M. Heagerty, S. Laurent, Lars Lindholm, G. Mancia, Athanasios Manolis, Peter M. Nilsson, Josep Redón, Roland E. Schmieder, Harry A.J. Struijker-Boudier, Margus Viigimaa, Document Reviewers:, G. Filippatos, Stamatis Adamopoulos, Enrico Agabiti‐Rosei, E Ambrosioni, Vicente Bertoméu, D Clément, Serap Erdine, Csaba Farsang, D. Gaita, W. Kiowski, Gregory Y.H. Lip, Jean-Michel Mallion, Athanasios Manolis, Peter M. Nilsson, Eoin O’Brien, Piotr Ponikowski, Josep Redón, Frank Ruschitzka, Juan Tamargo, PA van Zwieten, Margus Viigimaa, Bernard Waeber, Bryan Williams, José Luis Zamorano - European Heart Journal 2006 cited by 2,388

  6. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R Estacio, Robert Fagard, Kim Fox, Takahiro Fukui, Ajay Gupta, Rury R. Holman, Y. Imai, Masao Ishii, Stevo Julius, Yoshihiko Kanno, Sverre E. Kjeldsen, John B. Kostis, K Kuramoto, Jan Lanke, Edmund J. Lewis, Jeff Lewis, Michel Lièvre, Lars Lindholm, Stephan Lueders, Stephen MacMahon, G. Mancia, M Matsuzaki, Maria H. Mehlum, Steven Nissen, Hiroshi Ogawa, Toshio Ogihara, Takayoshi Ohkubo, C. Palmer, Anushka Patel, Carl J. Pepine, Michael Pfeffer, N. Poulter, Hiromi Rakugi, Gianpaolo Reboldi, Christopher M. Reid, Giuseppe Remuzzi, Piero Ruggenenti, T Saruta, Joachim Schrader, Robert W. Schrier, Peter S. Sever, Peter Sleight, Jan A. Staessen, Hiromichi Suzuki, Lutgarde Thijs, Kenji Ueshima, Seiji Umemoto, Wiek H. van Gilst, Paolo Verdecchia, Kristian Wachtell, Paul K. Whelton, L. Wing, Mark Woodward, Yoshiaki Yui, Salim Yusuf, Alberto Zanchetti, Z Y Zhang, Craig S. Anderson, Colin Baigent, Brenner Bm, Richard Collins, Dick de Zeeuw, Jacobus Lubsen, Ettore Malacco, Bruce Neal, Vlado Perkovic, Bertram Pitt, Anthony Rodgers, Peter M. Rothwell, Gholamreza Salimi-Khorshidi and 4 more - The Lancet Oncology 2021 cited by 104

  7. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2005 cited by 827

  8. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , - The Lancet 2009 cited by 331

  9. Clinical Practice Guidelines for the Management of Hypertension in the Community

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Hypertension 2013 cited by 1,000

  10. Divergent Results Using Clinic and Ambulatory Blood Pressures

    Authors: , , , , , , , , - Hypertension 2010 cited by 195

  11. The impact of serum uric acid on cardiovascular outcomes in the LIFE study

    Authors: , , , , , , , , , , , , , , , , , - Kidney International 2004 cited by 476

  12. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

    Authors: , , , , , , , , , , , , - The Lancet 1999 cited by 2,012

  13. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

    Authors: , , , , , - The Lancet 1991 cited by 1,893

  14. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

    Authors: , , - The Lancet 2005 cited by 993

  15. Systolic pressure is all that matters

    Authors: , , - The Lancet 2008 cited by 197

  16. Mobile App for Treatment of Stress Urinary Incontinence: A Cost-Effectiveness Analysis

    Authors: , , - Journal of Medical Internet Research 2017 cited by 89

  17. The burden of high workload on the health-related quality of life among home care workers in Northern Sweden

    Authors: , , , , - International Archives of Occupational and Environmental Health 2020 cited by 56

  18. Estimating a social value set for EQ-5D-5L in Sweden

    Authors: , , , , - Health and Quality of Life Outcomes 2022 cited by 34

  19. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2002 cited by 1,571

  20. Atenolol in hypertension: is it a wise choice?

    Authors: , , - The Lancet 2004 cited by 568

  21. Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death

    Authors: , , , , , , , , , - Circulation 2007 cited by 226

  22. Delay to celiac disease diagnosis and its implications for health-related quality of life

    Authors: , , , , - BMC Gastroenterology 2011 cited by 173

  23. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

    Authors: , , , , , , , , - The Lancet 1999 cited by 1,448

  24. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

    Authors: , , , , , , , , , - The Lancet 2000 cited by 902